AV8 Ventures

2018

Founded

30

Investments

United States

Offices

Venture Fund

Investor Type

About

AV8 Ventures is an early-stage venture capital firm founded in 2018, with offices in Palo Alto, California, and London, United Kingdom. The firm specializes in investing in seed and Series A startups across sectors such as healthcare, enterprise technology, financial services, and deep-tech. Backed by Allianz SE, AV8 Ventures focuses on partnering with visionary entrepreneurs to build category-defining companies.

The firm's team comprises experienced professionals with backgrounds in launching products, building teams, and scaling revenue, offering hands-on support to portfolio companies. Their network includes experts in health, machine learning, enterprise technology, mobility, robotics, hard sciences, and biology, providing comprehensive assistance to startups. Notable investments include Alpha Medical, Delfi Diagnostics, Eclypsium, and Embrace.io.

Portfolio Companies

Alpha Medical, Delfi Diagnostics, Eclypsium, Embrace.io

Gepgraphic Focus

United States, United Kingdom, Germany, Israel

Key Differentiators

Experienced team with decades of experience in launching products, building teams, and scaling revenue, Hands-on approach with significant time spent assisting entrepreneurs in overcoming unique challenges, Broad and deep networks connecting entrepreneurs to potential end-buyers, channel partners, and new hires, Venture Advisor team of leading domain experts available to assist entrepreneurs

Thypical Investment Size

$500K - $8M

Total Funds Raised

$180 million

Visit Website

Cybersecurity

Enterprise

Artificial Intelligence & Machine Learning (AI/ML)

Creator Economy

Software

Palo Alto

Pre-Seed

Seed

Series A

United States